RDHL ▲ +4.2% - RedHill Biopharma Ltd. $RDHL RDHL RDHL - $2.9 Million NCI Grant Awarded for Clinical Development of RedHill's Opaganib and CAR T-Cell Combination in Ultra-High-Risk Multiple Myeloma 19-OCT-2026 08:01 AM ET